The new issue of ONCOLife, one of the leading oncology magazines for healthcare professionals, is now available — and it ...

Despite two decades of clinical experience with Everolimus in transplant medicine, cancer patients continue to face ...

START and OneOncology are launching three new early-phase cancer trial sites in California, Texas, and New Jersey, expanding access in community settings where 70% of patients receive care.

IMUNON’s Phase 2 OVATION 2 trial of IMNN-001 in advanced ovarian cancer showed a 13-month OS increase (46 vs. 33 months) and ...